0001628280-26-028425
SEC filingTriSalus Life Sciences announced the planned retirement of Chief of Clinical Operations Jodi Devlin effective October 1, 2026, and the previously announced appointment of Dr. Richard Marshall as Chief Medical Officer effective June 29, 2026.
The departure of Jodi Devlin from her role as Chief of Clinical Operations, planned for October 1, 2026, follows her notice provided on April 24, 2026, representing a scheduled transition in a key clinical leadership position. The company acknowledged her contributions positively. Concurrently, the filing references the prior appointment of Dr. Richard Marshall as Chief Medical Officer effective June 29, 2026, indicating proactive succession planning in medical and clinical leadership ahead of Devlin's exit.